We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Barcode Band Identifies Blood Recipients

By LabMedica International staff writers
Posted on 28 Jul 2010
A blood recipient ID wristband system provides automated patient identification for blood transfusion, specimen collection, and tracking.

The snap closure product enables caregivers and phlebotomists to apply the band to patients quickly, correctly, and securely. More...
It uses serialized barcode ID and alphanumeric codes to match the right patient to the right blood. This improves patient safety by reducing identification-related human errors that can occur during the blood transfusion process.

The system's 12 matching barcode labels (four on the wristband and eight on the detachable tail that is applied to blood tubes) can be applied to additional drawtubes, patient chart, transfusion requisition, and as a secondary label on blood bags. A clear, adhesive shield on the wristband's information area protects the patient ID labels and barcode from moisture or solvents for accurate barcode scanning. Soft, latex-free material that is also durable and strong maximizes patient comfort and safety.

The Securline Bar Code Blood Band was released by Precision Dynamics Corp. (PDC; San Fernando, CA, USA). The product meets current Joint Commission (USA), American Heart Association (AHA), and The Health Insurance Portability and Accountability Act (HIPAA; USA) requirements.

PDC produces safe ID solutions that provide positive clinical outcomes. Its wristband and label systems are used in hospitals worldwide and they reach every touch point in the delivery of care--from admissions to discharge.

Related Links:

Precision Dynamics Corp.
Joint Commission
American Heart Association
The Health Insurance Portability and Accountability Act



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Prefilled Tubes
Prefilled 5.0ml Tubes
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.